Methods Subjects and drug administration. This study was conducted in agreement with the Declaration of Helsinki and was approved by the institutional ethics committee. Fifteen consecutive patients were included who underwent an elective aortic valve replacement with bileaflet mechanical prostheses (St Jude Medical). Informed consent was obtained from each participant. Drugs affecting hemostasis (including aspirin) had been terminated at least 7 days before surgical intervention. Antithrombotic therapy was initiated the first day after surgical intervention with heparin (3 10,000 IU administered subcutaneously). At day 3 after surgical intervention, anticoagulation with a vitamin K antagonist (phenprocoumon) was initiated, and heparin was terminated when a target international normalized ratio (INR) of 2.5 had been reached. Measurement of platelet function. One day before and at days 1, 5, and 10 after surgical intervention arachidonic acid (1 mmol/L)–induced aggregation and thromboxane formation were determined in venous blood samples. 2 Because thromboxane formation by platelet cyclooxygenase is the pharmacologic target of aspirin, the sensitivity of platelets to aspirin in vitro was determined by means of addition of aspirin (100 mol/L). Statistics. Data are presented as mean values the standard error of the mean. Statistical analyses were performed with 2-way analysis of variance for repeated measurements with the Tukey post-hoc test.